Name: IRMD Income Statement - Iradimed Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

IRMD - Iradimed Corp.

USD | NASDAQ | Healthcare

IRMD Income Statement - Iradimed Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	22.0	22.7	21.2	20.4	19.5	19.4	18.3	17.9	17.6	17.5	16.5	16.1	15.5	14.9	13.4	12.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013
Revenues
Revenues	86.3	83.8	73.2	65.6	53.3	41.8	31.7	38.5	30.4	23.1	32.5	31.6	15.7	11.3
Cost of Revenue	20.0	19.5	16.9	15.4	12.0	9.8	8.1	8.8	7.2	5.6	6.2	5.8	3.4	2.9
Gross Profit	66.3	64.3	56.4	50.2	41.3	32.0	23.6	29.7	23.2	17.5	26.3	25.8	12.2	8.5
Operating Expenses
Research & Development	3.3	3.0	2.8	2.9	2.3	1.9	1.9	1.4	1.5	1.7	1.3	1.8	1.1	1.0
Operating Income
Operating Income	28.0	26.1	22.0	20.0	15.6	9.8	(0.8)	8.6	6.0	1.3	10.9	11.5	3.1	2.8
Non-Operating
Interest Income	-	2.0	2.2	1.9	0.6	0.0	0.1	0.4	0.2	0.1	0.1	0.1	0.0	-
Interest Expense
Tax & Net
Income Tax Expense	6.6	5.9	5.0	4.5	3.4	0.5	(2.0)	(0.6)	(0.1)	0.9	3.7	4.1	1.0	0.8
Net Income From Continuing Ops
Per Share
EPS Basic	1.85	1.77	1.52	1.36	1.02	0.76	0.11	0.85	0.59	0.05	0.67	0.68	0.23	0.28
EPS Diluted
Supplementary Data
EBITDA	29.4	27.3	22.8	20.8	16.3	11.2	0.6	9.9	7.1	2.6	11.9	12.3	3.2	2.9
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Per Share
EPS Basic	0.46	-	0.44	0.45	0.37	-	0.40	0.39	0.33	-	0.40	0.33	0.27	-	0.27	0.26	0.20	-	0.21	0.12	0.11	-	0.09	(0.17)	0.15	-	0.22	0.19	0.17	-	0.22	0.13	0.08	-	0.02	0.03	(0.02)	-	0.15	0.21
EPS Diluted	0.45	-	0.43	0.45	0.37	-	0.40	0.38	0.32	-	0.40	0.33	0.27	-	0.27	0.26	0.20	-
Shares Basic	12.8	-	12.7	12.7	12.7	-	12.7	12.7	12.7	-	12.6	12.6	12.6	-	12.6	12.6	12.6	-
Shares Diluted	12.9	-	12.9	12.8	12.8	-	12.8	12.8	12.7	-	12.7	12.7	12.7	-	12.6	12.6	12.7	-

Operating Expenses
Research & Development	1.0	0.8	0.7	0.9	0.6	0.6	0.6	0.8	0.8	(1.6)	0.5	1.0	3.0	0.6	0.5	0.7	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.5	0.4	0.5	0.3
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	4.1	4.6	4.6	4.0	4.2	4.5	3.8	3.5	3.8	5.5	2.9	2.9	0.8	3.7	3.0	2.9	3.1
General & Administrative	4.6	4.5	4.4	4.3	4.6	3.9	4.0	4.1	4.0	4.3	3.6	3.3	3.9	2.7	2.9	2.4	2.7
Depreciation & Amortization	0.5	0.6	0.3	0.1	0.2	0.3	0.1	0.1	0.2	0.3	0.2	0.2	0.2	(0.0)	0.1	0.1
Amortization of Intangibles	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	9.6	9.9	9.7	9.2	9.4	9.0	8.4	8.4	8.6	8.3	6.9	7.2	7.7	7.0	6.4	6.0

Operating Income
Operating Income	7.2	7.1	6.8	6.8	5.4	5.8	5.8	5.6	4.7	5.2	5.9	5.0	4.0	4.3	4.1	4.2	3.1	3.1	3.1	1.8	1.8	0.7	0.8	(2.9)	0.7	2.2	2.5	2.4	1.5	1.8	1.4	1.7	1.1	1.0	0.2	0.3	(0.2)	1.5	2.6	3.3

Supplementary Data
EBITDA	7.7	7.7	7.1	6.9	5.6	6.1	5.9	5.8	5.0	5.4	6.1	5.1	4.2	4.2	4.3	4.3	3.5	3.9	3.2	2.0	2.1	1.4	0.9	(2.8)	1.1	2.8	2.6	2.5	1.9	2.2	1.6	1.8	1.5	1.8	0.3	0.4	0.0	2.3	2.7	3.4
EBIT	7.2	7.1	6.8	6.8	5.4	5.8	5.8	5.6	4.7	5.2	5.9	5.0	4.0	4.3	4.1	4.2	3.1	3.1	3.1